These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18395356)

  • 41. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation.
    Chen ET; Mohiuddin M; Brodovsky H; Fishbein G; Marks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):169-75. PubMed ID: 8083110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial.
    Loi S; Ngan SY; Hicks RJ; Mukesh B; Mitchell P; Michael M; Zalcberg J; Leong T; Lim-Joon D; Mackay J; Rischin D
    Br J Cancer; 2005 Feb; 92(4):655-61. PubMed ID: 15700033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity.
    Schaffer M; Thoma M; Wilkowski R; Schaffer P; Dühmke E
    Onkologie; 2002 Aug; 25(4):352-6. PubMed ID: 12232487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A retrospective comparison of concurrent bolus 5-fluorouracil or raltitrexed in preoperative chemoradiation for locally advanced rectal cancer.
    Yoney A; Askaroglu B; Hancilar T; Isikli L; Unsal M
    Hematol Oncol Stem Cell Ther; 2008; 1(1):28-33. PubMed ID: 20063525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients.
    Dunst J; Semlin S; Pigorsch S; Müller AC; Reese T
    Strahlenther Onkol; 2000 Sep; 176(9):416-21. PubMed ID: 11050915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy.
    Olsen CC; Schefter TE; Chen H; Kane M; Leong S; McCarter MD; Chen Y; Mack P; Eckhardt SG; Stiegmann G; Raben D
    Am J Clin Oncol; 2009 Apr; 32(2):115-21. PubMed ID: 19307945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck.
    Caponigro F; Romano C; Milano A; Solla R; Franchin G; Adamo V; Mari E; Morrica B; Pepe S
    Anticancer Drugs; 2008 Aug; 19(7):739-44. PubMed ID: 18594217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rationale for a phase I/II radiation dose-escalation study with concurrent amifostine (Ethyol) and infusional 5-FU chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.
    Myerson R
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):86-90. PubMed ID: 11917291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line.
    Palumbo I; Piattoni S; Valentini V; Marini V; Contavalli P; Calzuola M; Vecchio FM; Cecchini D; Falzetti F; Aristei C
    Int J Colorectal Dis; 2014 Jan; 29(1):31-41. PubMed ID: 23917393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial.
    Miller RC; Sargent DJ; Martenson JA; Macdonald JS; Haller D; Mayer RJ; Gunderson LL; Rich TA; Cha SS; O'Connell MJ
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):409-13. PubMed ID: 12243815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up.
    Gambacorta MA; De Paoli A; Lupattelli M; Chiloiro G; Solazzo AP; Barbaro B; Alfieri S; Vecchio FM; Lenkowicz J; Navarria F; Palazzari E; Bertola G; Frattegiani A; Minsky B; Valentini V
    Clin Transl Radiat Oncol; 2018 Mar; 10():23-28. PubMed ID: 29928702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORIT.
    Merx K; Martens UM; Kripp M; Hoehler T; Geissler M; Gaiser T; Mai S; Kienle P; Belle S; Plöger C; Hieber U; Wenz F; Post S; Hofheinz RD
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):867-875. PubMed ID: 28870789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma.
    Miller RC; Martenson JA; Sargent DJ; Kahn MJ; Krook JE
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):593-8. PubMed ID: 9635707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer.
    Buijsen J; Lammering G; Jansen RL; Beets GL; Wals J; Sosef M; Den Boer MO; Leijtens J; Riedl RG; Theys J; Lambin P
    Radiother Oncol; 2013 May; 107(2):184-8. PubMed ID: 23647753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy in addition to preoperative radiotherapy in locally advanced rectal cancer - a systematic overview.
    Glimelius B; Holm T; Blomqvist L
    Rev Recent Clin Trials; 2008 Sep; 3(3):204-11. PubMed ID: 18782078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I study.
    James RD; Botwood N; Vernon CC; Price P
    Ann Oncol; 2003 Apr; 14(4):570-3. PubMed ID: 12649103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase 1-2 trial of superselective carboplatin, low-dose infusional 5-fluorouracil and concurrent radiation for high-grade gliomas.
    Larner JM; Phillips CD; Dion JE; Jensen ME; Newman SA; Jane JA
    Am J Clin Oncol; 1995 Feb; 18(1):1-7. PubMed ID: 7847251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical adjuvant therapy of rectal cancer.
    O'Connell MJ; Gunderson LL; Fleming TR
    Semin Oncol; 1988 Apr; 15(2):138-45. PubMed ID: 3285477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with radiotherapy and chemotherapy in patients with rectal cancer.
    Huang CW; Hu HM; Hsu WH; Chen CY; Huang MY; Chen CP; Wei PL; Shen BN; Wang JY
    Nanomedicine (Lond); 2023 Mar; 18(6):511-524. PubMed ID: 37166053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis.
    Chiloiro G; Romano A; Cusumano D; Boldrini L; Panza G; Placidi L; Meldolesi E; Nardini M; Meffe G; Nicolini G; Votta C; Indovina L; Gambacorta MA
    Radiat Oncol; 2023 Oct; 18(1):163. PubMed ID: 37803322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.